Heatwave Warning: Weight Loss Jabs & Dehydration Risk

With record-breaking temperatures expected this weekend, individuals taking weight loss injections, particularly GLP-1 receptor agonists like semaglutide, are being advised to take extra precautions against dehydration. These popular medications, while effective for obesity treatment, can exacerbate fluid loss due to common side effects such as nausea, vomiting, and diarrhea.

The slowing of gastric emptying, a mechanism that helps users feel fuller longer, also contributes to a potential decrease in overall fluid and food intake. This reduced intake, coupled with increased fluid loss from sweating in hot weather, makes users more vulnerable to dehydration-related illnesses like heat exhaustion and heatstroke.

Experts emphasize the importance of proactive hydration, recommending regular fluid intake throughout the day rather than waiting for thirst. Adults typically need 1.5-2 liters of fluid daily, with increased amounts advised during heatwaves. Beyond dehydration, a lesser-known risk associated with rapid weight loss and these medications is an increased chance of gallstones, which may be further compounded by dehydration affecting bile flow.

Anyone experiencing persistent dizziness, severe fatigue, worsening nausea, or other dehydration symptoms should seek immediate medical advice. Prompt attention is crucial to manage potential health complications arising from the combination of heat and medication effects.